Related by context. All words. (Click for frequent words.) 90 Acute Bacterial Skin 76 Escherichia coli Klebsiella pneumoniae 75 Skin Structure Infections 74 spore forming bacterium Bacillus 73 Streptococcus pneumoniae Haemophilus influenzae 73 Complicated Skin 72 Enterobacter cloacae 71 Acute Bacterial Sinusitis ABS 71 methicillin susceptible Staphylococcus aureus 70 bacterium Neisseria meningitidis 70 infections cIAI 70 bacteria Neisseria meningitidis 69 human rhinovirus HRV 69 HPV Types 69 Fungal Infections 68 vaginal candidiasis 68 Ribavirin causes 68 methicillin resistant S. aureus 68 included exfoliative dermatitis 68 bacterium Chlamydia trachomatis 68 cramping abdominal pain 68 MDR Gram negative 68 Antibiotic Resistant 67 Drug Resistant 67 systemic lupus erythematosus psoriasis 67 infection sinusitis 67 Phase 2b Clinical Trial 67 Chronic Bronchitis 67 Vaccine Candidate 67 Potentially Fatal 67 bacterium Mycobacterium tuberculosis 67 Diabetic Neuropathic Pain 67 Epstein Barr Virus EBV 67 MRSA Infections 67 Shows Promise Against 67 right sided endocarditis 67 Refractory Hodgkin Lymphoma 66 Severe cutaneous 66 Vancomycin resistant 66 Cryptococcus neoformans 66 Moraxella catarrhalis 66 Staphylococcus aureus methicillin susceptible 66 NASH Huntington 66 Allergic Rhinitis 66 Chronic Hepatitis B 66 Acute Exacerbations 66 VRE Vancomycin resistant Enterococcus 66 Inflammatory Diseases 66 Advanced Melanoma 66 Combination REOLYSIN R 66 Adenoviral 66 Complicated intra abdominal 66 Vaccine Adjuvant 66 Mouse Model 66 Meets Primary Endpoint 66 Staphylococcus aureus MRSA 66 Angioedema 66 Respiratory Syncytial Virus 66 dyspnea pulmonary infiltrates pneumonitis 66 Resistant Staphylococcus Aureus 66 parasite Trypanosoma cruzi 66 brand ciclesonide HFA 65 Successfully Treated 65 Treatment Shows Promise 65 Bacterial Infections 65 Methicillin resistant 65 Malignant Melanoma 65 enterocolitis caused 65 investigational oral inhibitor 65 Shows Promising 65 Antiviral Drugs 65 Oral Fingolimod 65 CYP#A# CYP#D# 65 Antifungal 65 Streptococcus pyogenes 65 pseudomembranous colitis 65 Histoplasmosis 65 Experimental Vaccine 65 bacterium Francisella tularensis 65 Resistant Staph 65 Treatment Naive Patients 65 Single Dose 65 Liver Injury 65 bacteria Pseudomonas aeruginosa 65 Cutaneous T 65 Soft Tissue Sarcoma 65 Skin Infection 65 Chronic Sinusitis 65 cryptococcosis 65 Hemorrhagic 65 genus Plasmodium 65 Completes Patient Enrollment 65 methicillin resistant MRSA 65 Improves Outcomes 65 Diabetic Foot Ulcers 65 cSSSIs 65 Streptococcus pneumoniae pneumococcus 65 microorganisms Staphylococcus aureus 65 Skin Infections 65 Community Acquired Pneumonia 65 receiving XGEVA 65 myocardial infarction ventricular fibrillation 65 Pooled Analysis 65 gastroenteritis conjunctivitis 65 Mucositis 65 Slow Progression 65 carbapenem resistant 65 Progressive Multifocal Leukoencephalopathy 65 parasite plasmodium 65 including thyroiditis RA 64 TNF Blockers 64 Amgen Neulasta R 64 Staphylococcus Aureus 64 lichen planus 64 Demonstrates Positive 64 Infusion Reactions Severe 64 Primary Hypercholesterolemia 64 nonbacterial 64 T. mentagrophytes 64 Drug Prevents 64 Novel Oral 64 Stomatitis 64 Adjuvant Chemotherapy 64 varicella zoster virus VZV 64 Squamous Cell Carcinoma 64 disease CDAD 64 carcinoma mCRC 64 diaper dermatitis complicated 64 humans variant Creutzfeldt 64 Lupus Nephritis 64 diarrhea colitis 64 Bronchopulmonary Dysplasia 64 complement inhibitor eculizumab 64 difficile associated 64 Inhaled Nitric Oxide 64 Lowers Risk 64 Initiates Enrollment 64 Myeloma Patients 64 Leukemias 64 Study Evaluating 64 Renal Impairment 64 Candida infections 64 Severe Sepsis 64 Files IND 64 Treatment Reduces 64 Clostridium difficile Infection 64 erythematosus 64 Allergic Reactions 64 abdominal cramping vomiting 64 Systemic lupus erythematosus SLE 64 structure infections ABSSSI 64 Clostridium Difficile Associated 64 acute porphyria 64 nausea vomiting abdominal cramping 64 ST Elevation Myocardial 64 vancomycin resistant Staphylococcus aureus 64 bacterium Streptococcus 64 Serious Infections 64 metabolic alkalosis 63 Antifungals 63 paralytic illness 63 cheilitis 63 oral thrush 63 Drug Combo 63 dasatinib Sprycel ® 63 Naive Patients 63 Phase 2b Trial 63 Immune Responses 63 Viral Infection 63 Haemophilus influenza 63 Vulvar 63 MRSA Clostridium difficile 63 Genes Predict 63 Prolongs Survival 63 Candidiasis 63 Endocarditis 63 Nebulized 63 Hypotension 63 Potentially Deadly 63 essential thrombocythemia ET 63 inhalation anthrax cutaneous anthrax 63 Bacteremia 63 Genital Warts 63 Phase IIb Trial 63 autoimmune disorder characterized 63 Proves Effective 63 Phase 2b Study 63 Papillomavirus 63 Improves Survival 63 Endothelial Cells 63 Diabetic Neuropathy 63 Elderly Patients 63 Vitrasert ® 63 Hormone Refractory Prostate Cancer 63 Appears Safe 63 Atopic Dermatitis 63 Knee Osteoarthritis 63 congenital ichthyosis 63 simplex virus 63 itraconazole Sporanox 63 Phase III Clinical Trial 63 includes S. anginosus 63 Carcinomas 63 Vaccine Protects Against 63 Antitumor Activity 63 Impetigo 63 Toxicities 63 Esophagitis 63 Staphylococcus aureus infections 63 Receives Orphan Drug Designation 63 Rotavirus Vaccines 63 inflammatory PDE 63 Clinical Trial Results 63 Chronic HCV 63 dermatologic reactions 63 Combination Treatment 63 Initiates Clinical Trial 63 Staphylococcus aureus S. aureus 63 penicillin resistant Streptococcus 63 Drug Candidate 63 Pediatric Patients 63 Enterococcus faecium 63 Bloodstream Infections 63 Sinus Infections 63 Staphylococcus epidermidis 63 Vaccine Shows Promise 63 Renal Cell Carcinoma 63 pruritus rash 63 Bacterial Infection 63 Invasive fungal infections 63 Rheumatoid Arthritis Patients 63 Dose Ranging Study 63 mycobacterium tuberculosis 63 Chronic Hepatitis C 63 Hospital Acquired Pneumonia 62 Critically Ill Patients 62 Catheter Associated 62 Secondary Hyperparathyroidism 62 Respiratory Syncytial Virus RSV 62 See CLINICAL PHARMACOLOGY 62 Initiate Phase 62 R Saizen R 62 Adjuvant Treatment 62 Relapsed Refractory 62 bacteria Streptococcus pneumoniae 62 Reduces Mortality 62 Interferon Beta 62 Multidrug Resistant 62 RG# nucleoside analog 62 Abdominal Pain 62 bacterium Bacillus anthracis 62 B Anflu R 62 Lymphoid 62 Myocarditis 62 hemorrhagic cystitis 62 Metastases 62 gastrointestinal GI perforation 62 septicemic 62 Investigational Treatment 62 Increased Mortality 62 Non Alcoholic Fatty 62 Antibiotic resistant 62 Am J Respir 62 severe hypersensitivity reactions 62 acetonide FA 62 bacteremic pneumonia 62 BioMarin develops 62 SPRYCEL ® 62 Prophylactic Treatment 62 methicillin resistant staph aureus 62 hypophosphatemia 62 associated diarrhea CDAD 62 Respiratory Virus 62 infections bloodstream infections 62 infectious sequelae eg blepharitis 62 uraemic syndrome HUS 62 Novel Treatments 62 R roscovitine CDK cyclin 62 Metastatic Colorectal Cancer 62 Mg Uk 62 Bloodstream infections 62 Lactic acidosis 62 CYT# potent vascular disrupting 62 Friedreich Ataxia FRDA 62 Improve Survival 62 full blown haemolytic 62 oral ferric iron 62 Genetic Mutation 62 Eye Fungus 62 Pivotal Phase III 62 Drug Resistant Bacteria 62 Squamous cell 62 Peritonitis 62 Patients Receiving 62 Previously Untreated 62 Plaque Psoriasis 62 Often Misdiagnosed 62 MKC# MT 62 Acute Renal Failure 62 Factor Receptor 62 bacterium Treponema pallidum 62 severe hepatomegaly 62 Rhinitis 62 Initiates Phase II 62 severe malignant osteopetrosis 62 dependent kinase inhibitor 62 epiglottitis 62 Iron Deficiency 62 Completes Enrollment 62 posterior uveitis 62 Treated Patients 62 By Ed Edelson 62 bacteria Mycobacterium tuberculosis 62 Herpes Simplex 62 Diabetic Macular Edema 62 Liver Failure 62 infectious diseases autoimmune diseases 62 Otitis 62 Postherpetic Neuralgia 62 contagious bacterial 62 Electrical Stimulation 62 Colorectal Adenomas 62 refractory gout 62 kidney urologic 62 hypothyroidism hyperglycemia hypotension arrhythmihemorrhagic colitis development 62 Tracheitis 62 vapreotide acetate 62 Hyperkalemia 62 Enterococcus faecalis vancomycin susceptible 62 Antibiotic Treatment 62 metastatic neuroendocrine tumors 62 Bone Fractures 62 headache abdominal pain 61 Helicobacter Pylori 61 hip osteonecrosis avascular 61 Parainfluenza 61 Xerostomia 61 PEGylated Fab fragment 61 Drug Shows Promise 61 Respiratory Infections 61 impairs digestion 61 Overactive Bladder 61 vaginal yeast infections 61 candida albicans 61 diarrhea abdominal cramps nausea 61 Aspergillosis 61 otitis media ear 61 Gum Disease 61 Herpes Zoster 61 Tyrosine Kinase Inhibitor 61 Atypical Hemolytic Uremic Syndrome 61 candidates Azedra TM 61 Cancer Patients Treated 61 Vancomycin Resistant 61 Rare Genetic 61 CYP#A# substrate 61 renal failure interstitial lung 61 castration resistant hormone refractory 61 S. aureus bacteremia 61 candidiasis 61 Test Detects 61 acute pharyngitis 61 Molecular Diagnostic Test 61 neutropenia dehydration dyspnea 61 Onychomycosis 61 parasite transmitted 61 causes diarrhea vomiting 61 Parathyroid 61 superficial basal cell carcinoma 61 Intracerebral Hemorrhage 61 Treating Chronic 61 S. aureus bloodstream infections 61 Investigational Agent 61 Unfractionated Heparin 61 Rotavirus causes 61 HER2 Positive 61 Viral Infections 61 Streptococcus Pneumoniae 61 purpura ITP 61 Clostridium difficile C. difficile 61 Chronic Wounds 61 Phase IIb Clinical Trial 61 Malignant Glioma 61 Female Stress Urinary 61 Anthrax Toxin 61 Keratitis 61 Wafer polifeprosan 61 Tezampanel 61 Mouse Models 61 Diarrheal 61 Metastatic Prostate Cancer 61 S.aureus 61 Unresectable 61 Entamoeba histolytica 61 nosocomial pneumonia 61 Telaprevir VX 61 vancomycin resistant Enterococcus faecium 61 Treatment Naïve 61 nausea diarrhea constipation 61 Advanced Prostate Cancer 61 dermatophytes 61 Successfully Completes Phase 61 Multiple Sclerosis Rheumatoid Arthritis 61 Hormone Receptor Positive 61 Sangamo BioSciences Announces 61 atypical Hemolytic Uremic Syndrome 61 sickle cell cystic fibrosis 61 Poliovirus 61 Streptococcus pneumoniae S. pneumoniae 61 bacterial exacerbation 61 Mosquito Borne 61 Staphyloccus aureus 61 Inactivation 61 hemorrhagic colitis development 61 Peanut Allergy 61 vascular occlusive diseases 61 Staphylococcal 61 Cutaneous 61 herpes labialis cold 61 Pancreatitis 61 Preclinical Data 61 Chlamydophila pneumoniae 61 immunocompetent patients 61 mit dem Ziel einer 61 Resistant Hypertension 61 Cancer Incidence Mortality 61 Pulmonary Arterial Hypertension 61 Infected Patients 61 Eye Infections 61 Systemic lupus erythematosus 61 oral prodrug 61 Genital Herpes 61 SinuNase TM 61 vancomycin resistant 61 Neisseria meningitides 61 Hepatitis C Viral 61 diarrhea scabies 61 Benign Prostatic Hyperplasia 61 Streptococcus agalactiae 61 Shigatoxin producing E. coli 61 Commences Phase 61 Dendritic Cells 61 Patients Treated With 61 Bacterial Vaginosis 61 cytomegalovirus infection 61 Genes Identified 61 Gastritis 61 MRSA Infection 61 Hereditary angioedema HAE 61 Stress Incontinence 61 Hepatitis C Virus 61 Clinically Significant 61 meningitis inflammation 61 Tamiflu Resistant 61 CASES OF 61 Streptococcus pneumonia 61 hyperammonemia 61 Prostate Tumors 61 Streptococci 61 Blood Clots 61 Lung Injury 61 K. pneumoniae 61 Dengue Virus 61 Premature Aging 61 Commercialize Novel 61 Chronic Prostatitis 61 Dementia Related Psychosis 61 Myelofibrosis 61 Bronchiectasis 61 Adenoma 61 ST Segment Elevation 61 Trial Evaluating 61 Patients Suffering 61 Bronchiolitis 61 Phase 2a Clinical Trial 61 By EJ Mundell 61 FUSILEV enhances 61 Inhibits 61 Tumor Targeting 61 Anticoagulant 61 thrombophlebitis 61 Inflammatory Markers 61 Patient Enrollment 60 R famotidine 60 Tumor Growth 60 Patients Undergoing 60 Pivotal Study 60 Cellulitis 60 Human papilloma virus 60 nephropathic cystinosis cystinosis 60 BAG# BAG# 60 Pulmonary Artery 60 E. coli Salmonella 60 Initiates Phase 60 urinary bladder wall 60 Is Well Tolerated 60 Trichophyton rubrum 60 cervical cancer genital warts 60 Cases Linked 60 Therapeutic Efficacy 60 Salmonella typhi 60 Host Disease GvHD 60 Carcinoid tumors 60 diarrhea CDAD 60 Previously Treated 60 herpes virus infections 60 Blood Clot Risk 60 Bosutinib 60 Kit CD# positive 60 Respiratory syncytial virus RSV 60 Fungal infections 60 carcinoids originate 60 Ear Infections 60 Pelvic Inflammatory Disease 60 vancomycin resistant enterococci VRE 60 Enlarged Prostate 60 LENALIDOMIDE 60 hypereosinophilic syndrome 60 Improved Survival 60 chronically immunosuppressed solid 60 Salmonella Shigella 60 opportunistic pathogens 60 Staph Infections 60 Flu Virus 60 Patients Treated 60 Obesity Linked 60 Canker sores 60 MEK Inhibitor 60 Urinary tract 60 venous stasis ulcers 60 causes watery diarrhea 60 hepatic failure 60 Pivotal Clinical Trial 60 nanofiltered plasma derived 60 Chronic Cough 60 Chemotherapy induced 60 Thrombotic 60 applying Lipid Sciences 60 Septic Shock 60 Pruvel TM 60 Vitro Activity 60 Clostridium perfringens 60 Malignancies 60 Achieves Primary Endpoint 60 protein tyrosine phosphatase 1B 60 Chagas Disease 60 Inflammatory Disease 60 Disease Modifying 60 NDA Submission 60 Pericarditis 60 bacterium Streptococcus pneumoniae 60 SARS Virus 60 nasal stuffiness 60 Metastatic Renal Cell Carcinoma 60 BY SUE KIESEWETTER 60 amikacin 60 Virus Infection 60 Survival Benefit 60 pralatrexate injection folate analogue 60 Endologix Powerlink System 60 Chlamydia trachomatis 60 idiopathic thrombocytopenic purpura ITP 60 Rotavirus Vaccine 60 II Clinical Trial 60 Unternehmen der EquityStory AG 60 tinea versicolor 60 Trypanosoma cruzi 60 Respiratory Illness 60 Provectus Pharmaceuticals specializes 60 Hepatocellular 60 Bone Metastases 60 receiving immunosuppressive therapy 60 resistant isolates Streptococcus 60 commercializes innovative biopharmaceuticals 60 Epidermal Growth Factor Receptor 60 Aflibercept 60 Cholangiocarcinoma 60 bullous 60 MRSA Methicillin 60 Potent Anti 60 Vaccine Prevents 60 Anti Tumor Activity 60 Stomach Cancer 60 methicillin sensitive 60 recurrent sinusitis 60 Necrotizing 60 Squamous 60 Epstein Barr Virus 60 Mitral Regurgitation 60 TO TREAT 60 Thrombocytopenia 60 novel VDA molecule 60 Hemolysis 60 Prospective Randomized 60 Radiofrequency Ablation 60 PROSTASCINT R 60 Hsp# Inhibitor 60 HAS BEEN PREPARED BY 60 Hip Fractures 60 Phase IIa Clinical Trial 60 Randomized Double blind 60 Gene Mutation 60 Chronic Lung 60 Shows Efficacy 60 AA Amyloidosis 60 humanized therapeutic 60 Cerebril TM 60 immune idiopathic thrombocytopenic 60 debilitating complication 60 Elotuzumab 60 Flu Symptoms 60 Skin Condition 60 Urinary Tract Infections 60 Chronic Renal Failure 60 sulfamethoxazole 60 Postmenopausal Women 60 Subarachnoid Hemorrhage 60 Tetanus Toxoids 60 Cell Lymphoma 60 BAG# BAG# BAG# BAG# 60 fungal nail 60 Dengue Hemorrhagic Fever 60 Peginterferon 60 Severe Asthma 60 severe obstructive pulmonary 60 NS5B polymerase 60 naturally occurring bacterium 60 Hepatitis B Virus 60 b Hib 60 Study Showed 60 induced mucositis 60 Rabies Dengue fever 60 Babesiosis 60 virus HCV infection 60 Gene Linked 60 soluble tumor necrosis 60 Monoclonal Antibody 60 Begins Dosing 60 fatal hemorrhagic 60 dehydration abdominal pain 60 Staph Aureus 60 pulmonary alveolar 60 candidemia 60 Preclinical Study 60 causes bloody diarrhea 60 Lung Cancers 60 Increased Risk 60 Granted Orphan Drug 60 THE SUNAMERICA FOCUSED ALPHA 60 bacterial intestinal 60 acute febrile 60 Prostate Cancer Patients 60 metastatic colorectal 60 Randomized Phase 60 Bacterial conjunctivitis 60 Phase 2a Trial 60 Sapacitabine 60 Hospital Acquired Infections 60 Diabetic Nephropathy 60 S. aureus isolates 60 Irritable Bowel 60 invasive candidiasis 60 proprietary delipidation technologies 60 monoclonal antibody IgG1 Mab 60 Peripheral Arterial 60 Fluorouracil 60 Hedgehog Pathway Inhibitor 60 asthma rhinitis 60 Novel Antibiotic 60 pre cancerous actinic 60 cystic fibrosis chronic pancreatitis 60 Acute Coronary 60 FDA Okays 60 Tumor Response 60 single celled parasite 60 INDUSTRY ASSESSMENTS 60 Demonstrates Significant 60 diarrhea headache nausea 60 Kinase Inhibitor 59 Hepatitis C Virus HCV 59 Autoimmune Diseases 59 staphylococcal infections 59 parasite Plasmodium falciparum 59 Poliomyelitis polio 59 administered concomitantly 59 DG# compounds targeting 59 TO AVOID PREGNANCY WHILE 59 Adjunctive 59 Shigella bacteria 59 rhinitis sinusitis 59 Gastroesophageal Reflux Disease 59 suppurative 59 vibrio parahaemolyticus bacteria 59 Bacterial infection 59 Eosinophilic 59 Relapsing Multiple Sclerosis 59 Breast Cancers 59 HER2 Positive Breast Cancer 59 Antidepressants Linked 59 Ebola Virus 59 Adjunctive Therapy 59 induce orthostatic hypotension 59 GRUMET Times Staff Writer 59 herpes keratitis Hepatitis C 59 agonistic human 59 Demonstrated Significant 59 Sleep Disturbances 59 Ventilator Associated 59 Immune Cells 59 Uterine Fibroid Embolization 59 Burkholderia pseudomallei 59 abdominal cramping diarrhea 59 gastrointestinal mucositis 59 particularly SANCTURA XR 59 PRN FDA Approves 59 viral bacterial 59 Combination Therapy 59 Nitazoxanide 59 chronic rheumatic 59 Anticancer Drugs 59 BY RYAN ERNST 59 Presents Positive 59 cSSSI 59 bacterial respiratory infections 59 Phase III Pivotal 59 MRSA Methicillin resistant Staphylococcus 59 Pivotal Phase 59 Peptic Ulcer 59 ovarian esophageal 59 Respiratory syncytial virus 59 By KEIRA BENSON 59 Methicillin resistant S. aureus 59 secondary bacterial infections 59 Genital herpes 59 fatal anaphylactic 59 Methicillin Resistant 59 Urinary tract infections 59 Genetic Variant 59 Panic Disorder 59 Wirtschaftsmeldungen auf ad hoc 59 superantigens 59 mRNAs thereby preventing 59 Acne Rosacea 59 painful sores 59 Myelodysplastic Syndrome MDS 59 Liprotamase 59 STOP COMPLAINING AND 59 INSPIRE Trial Phase III 59 Lupus Drug 59 BAG# 59 reduce serum phosphate 59 Cervical Dysplasia 59 treat musculoskeletal metabolic 59 Myelodysplastic Syndrome 59 Gastrointestinal Tract 59 Herpes simplex virus 59 contagious bacterial infection 59 Reflux Disease 59 Chronic Myeloid Leukemia 59 streptococcal toxic 59 Breathing Problems 59 Septicaemia 59 penile cancers 59 Lupus nephritis 59 Migraine Headaches 59 Initiates Phase III 59 Bilive R combined 59 Liver Cirrhosis 59 Kidney Failure 59 Ovitrelle R Serostim 59 Staphylococci 59 oropharyngeal candidiasis 59 Misdiagnosis 59 Non Invasive Treatment 59 myelofibrosis polycythemia vera 59 Flu Strain 59 RNAi Therapeutic 59 pancreas esophagus 59 Extensively drug 59 Anthracycline 59 Respiratory Distress 59 Propionibacterium acnes 59 fevers vomiting 59 BY JOHN ECKBERG 59 Initiate Phase III 59 Bullous 59 Influenza Virus 59 mastocytosis 59 Cases Confirmed 59 Reperfusion Injury 59 Acute Ischemic Stroke 59 severe oral mucositis 59 generation oxazolidinone 59 known teratogen substance 59 Chemotherapeutic Agents 59 Predict Risk 59 Nosocomial 59 primary immunodeficiency PI 59 fever headache tiredness 59 Smallpox Vaccine 59 capillary leak 59 virus HCV protease inhibitor 59 Difficulty breathing 59 Diffuse Large B 59 B Cell Lymphoma 59 meningoencephalitis 59 Hepatocellular Carcinoma 59 cutaneous lupus 59 Colon Polyps 59 Breast Cancer Recurrence 59 OR CONTRIBUTE TO SUCH 59 bacteria Borrelia burgdorferi 59 esophageal candidiasis 59 Digoxin toxicity 59 BY ANDREW LARSON 59 Pegylated Interferon 59 Herpes Simplex Virus 59 IMiDs ® 59 Abrupt discontinuation 59 Candida infection 59 Treatment Regimen 59 MANAGEMENT 'S CURRENT BELIEFS 59 dysplastic lesions caused 59 ALN HPN 59 Meningococcal Disease 59 Therapeutic Vaccine 59 Newly Diagnosed Chronic Myeloid 59 Omacetaxine 59 NEWS RELEASE THE COMPANY 59 VEGFR2 inhibitor 59 BY ROB WEILER 59 MRSA Superbug 59 Treatable 59 SMZ TMP 59 intravascular hemolysis 59 Enzastaurin 59 Well Tolerated 59 Controlled Study 59 Left Ventricular Hypertrophy 59 Helicobacter pylori H. pylori 59 Pneumocystis 59 Submits NDA 59 triggers apoptosis programmed 59 viral respiratory infections 59 spore forming bacterium 59 hypervirulent strain 59 BY JAMES MCNAIR 59 amebiasis 59 gastrointestinal stromal 59 CYP#A# isoenzyme 59 JECKBERG@ENQUIRER.COM 59 Recombinant interferon alpha 59 using Innocoll proprietary 59 sunitinib Sutent ® 59 bacteria Bacillus anthracis 59 rashes hives 59 Neoadjuvant Chemotherapy 59 Mayo Clinic Study Finds 59 Advanced Renal Cell 59 BY EILEEN MOZINSKI 59 profuse diarrhea 59 messenger RNAs mRNAs thereby 59 HCV Protease Inhibitor 59 Gene Mutations 59 anterior uveitis 59 Idiopathic Pulmonary Fibrosis 59 Present Preclinical Data 59 metastatic malignant 59 bacterial gastroenteritis 59 Aeolus Pharmaceuticals Announces 59 Organ Rejection 59 ATRA IV 59 BY DAVID KRECHEVSKY 59 gastroenteritis skin rashes 59 Diabetic Foot Ulcer 59 Skin Cancers 59 Newly Diagnosed Patients 59 NAGS deficiency 59 Relapsing Remitting Multiple Sclerosis 59 H. Pylori 59 resistant hormone refractory 59 Keratosis 59 cirrhosis liver failure 59 necrotizing pneumonia 59 including eniluracil ADH 59 aureus MRSA 59 Staphylococcus aureus MSSA 59 Node Positive 59 Metastatic Melanoma 59 ORENCIA ® 59 whooping cough polio 59 receiving FUSILEV 59 Tay Sachs thalassemia 59 IS NOT FOR DISSEMINATION 59 linezolid resistant 59 expanded autologous cellular 58 MTP inhibitor 58 Beta Blocker 58 Anti Tumor 58 Clinical Outcome 58 HDAC Inhibitor 58 ketoconazole itraconazole 58 Chronic Insomnia 58 DISPLAY AND SEARCH THE 58 failure ADHF 58 include Healive TM 58 Antiviral Activity 58 sepsis pneumonia 58 chronic immune thrombocytopenic 58 Viral Meningitis 58 Study Demonstrates 58 including HGF ErbB3 58 Adenoviruses usually cause 58 Includes KCI proprietary 58 BY RICK FOSTER SUN 58 herpes encephalitis 58 Multicenter Randomized 58 Genetic Variations 58 By RYAN BRINKS 58 Nymox NX 58 Epilepsy Drugs 58 Doctors Warn 58 Ischaemic heart 58 acting fibrinolytic 58 Hemolytic Uremic Syndrome 58 serogroup B 58 CRM# Protein 58 Flu Viruses 58 Cryptosporidium parvum 58 resistant Staphylococcus aureus MRSA 58 Newly Diagnosed Multiple Myeloma 58 Yeast Infections 58 Initiate Clinical Trial 58 Philadelphia Chromosome Positive 58 Albuferon TM 58 Fluoroquinolones 58 Vertebral Fractures 58 Virus Vaccine 58 Venous Thromboembolism 58 Hookworm 58 Vidaza ® 58 Erythropoietic therapies may 58 diabetic retinopathy hyphema glaucoma 58 JAK2 Inhibitor 58 Aggressive Prostate Cancer 58 Tyrosine Kinase Inhibitors 58 immunocompromised patients 58 Surgical Procedures 58 RNAi Therapeutics 58 Valvular Heart Disease 58 Follicular Lymphoma 58 Safinamide 58 hemoptysis 58 Aliskiren 58 Confirmed Cases 58 Generalized Anxiety Disorder 58 alpha folate receptor 58 Therapeutic Effects 58 hemorrhagic fever viruses 58 Immunotherapeutic 58 anginosus group 58 Gastric Cancer 58 ODT metoclopramide HCl PEPCID 58 valacyclovir Valtrex 58 Francisella tularensis 58 Klebsiella bacteria 58 adalimumab Humira 58 haberin 58 Osteoporosis Drugs 58 Dupuytren Contracture 58 Typhoid fever 58 ARE PRESENTED FOR INFORMATIONAL 58 Staph Infection 58 Progenitor Cells 58 Streptococcal 58 Demonstrates Potent 58 aeruginosa 58 Foodborne 58 irritation rashes 58 asthma rheumatoid arthritis 58 sorafenib tablets 58 bacterium Borrelia burgdorferi 58 nonfatal diarrhea 58 bacteraemia 58 Tumor Necrosis Factor 58 Brentuximab Vedotin SGN 58 Irinotecan 58 interferon alpha IFN 58 Blood Cancers 58 Scabies 58 serotonin syndrome 58 Peginterferon alfa 2b 58 Taxane 58 E. coli STEC 58 dysentery hepatitis 58 monoclonal antibody conjugated 58 haemolytic uraemic syndrome 58 Thromboembolic 58 microbial biofilms